Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TRILACICLIB vs TRIMEPRAZINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TRILACICLIB vs TRIMEPRAZINE: Safety Overview

Metric TRILACICLIB TRIMEPRAZINE
Total FAERS Reports 226 3,601
Deaths Reported 29 548
Death Rate 12.8% 15.2%
Hospitalizations 96 2,280
Average Patient Age 62.2 yrs 43.9 yrs
% Female Patients 43.9% 57.1%
FDA Approval Date Feb 12, 2021 Approved Prior to Jan 1, 1982
Manufacturer Pharmacosmos Therapeutics Inc. N/A
Route INTRAVENOUS N/A
Marketing Status Prescription Discontinued